Flagship Ventures Fund IV General Partner LLC, 10% Owner at Evelo Biosciences, Inc. (EVLO), bought 8,658,008 shares at $2.31 ($20.0M) on 2023-07-11, disclosed to the SEC on 2023-07-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.31 | 1,082,251 | $2.5M | 12.5% |
| 2 | $2.31 | 1,082,251 | $2.5M | 12.5% |
| 3 | $2.31 | 3,246,753 | $7.5M | 37.5% |
| 4 | $2.31 | 3,246,753 | $7.5M | 37.5% |
| Total | $2.31 avg | 8,658,008 | $20.0M | 100% |
| Filing → |